Singapore, April 27 -- IMG Pharmaceutical Co, a majority-owned subsidiary of IMG Japan, the Group's holding company, has entered into a definitive agreement to acquire Matsumoto Pharmaceutical Co, a Japanese pharmaceutical manufacturer.

IMG Medical Group operates an integrated healthcare platform across Asia, providing structured clinical services and long-term health management across the full lifecycle of care-from life creation and optimisation to preservation. Within this framework, IMG Pharma serves as the Group's pharmaceutical and product platform, translating clinical needs and medical pathways into standardized, scalable pharmaceutical and health products.

Founded in 1948, Matsumoto Pharmaceutical has established a mature OTC p...